The Damouni Group Announces Launch of Strategic Communications and Corporate Affairs Agency
06 August 2024 - 1:10PM
Business Wire
The Damouni Group, LLC (“Damouni Group”), a strategic
communications and corporate affairs agency dedicated to the life
sciences sector, announced its launch today. Under the leadership
of founder Sasha Damouni Ellis, a seasoned media and investor
relations expert, Damouni Group will establish a new standard for
impactful and results-driven communications across key stakeholder
audiences.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240806799548/en/
Founding Partner, Sasha Damouni Ellis
(Photo: Business Wire)
“Over the last decade, I’ve witnessed communications evolve into
a more cross-functional role, emphasizing shared metrics beyond
traditional publicity and media relations. It is increasingly
important to integrate investor, patient, policy, and other
stakeholder perspectives into the overall storytelling strategy,
particularly in early to mid-stage life science companies,” said
Sasha Damouni Ellis, Founding Partner of Damouni Group. “We’re
excited to establish an advisory agency which offers a corporate
affairs perspective that empowers clients to navigate the dynamic
healthcare landscape throughout every step of a company’s life
cycle.”
Damouni Group builds on Sasha Damouni Ellis's 20+ years of
experience as a healthcare journalist and corporate communications
officer. She provides guidance on stakeholder engagement, narrative
development, and measurable outcomes to drive business success. Ms.
Damouni Ellis has previously served as Chief Corporate Affairs
Officer at Vir Biotechnology, an immunology-focused company, and as
Senior Vice President of Corporate Affairs and Investor Relations
at Marinus Pharmaceuticals, specializing in rare seizure disorders.
She also led external communications and media relations at Bayer
U.S., executing brand-building campaigns in oncology, hemophilia,
cardio-pulmonary, and women’s health. Earlier in her career, Ms.
Damouni Ellis was a Healthcare Journalist at Bloomberg News and
Global Editor of BioPharm Insight (Pharmawire), formerly a division
of the Financial Times Group, which she launched in New York and
London.
With a commitment to excellence, Damouni Group leverages a
network of experts and providers to deliver a comprehensive suite
of services, including issues and crisis management, restructuring
and litigation, as well as creative marketing and branding. This
approach ensures effective program management, operational
efficiency, and strategic counsel for its clients.
About Damouni Group
Damouni Group launched in 2024, as a full-service strategic
communications and corporate affairs firm for the healthcare and
life science sector. The Company’s Founding Partner has over 20
years of media and investor relations experience, providing clients
with the resources to build and protect their reputations during
key events, including product launches, regulatory approvals,
M&A, crisis and change management, as well as driving patient
advocacy and public policy engagement. Damouni Group has a network
of partners that support product communications, branding, and
marketing. For more information, please visit
www.damounigroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240806799548/en/
info@damounigroup.com